Nursing front in the fight against streptococcal infection in children and adolescents

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Streptococcal infection is characterized by a variety of manifestations, from asymptomatic carriage of the pathogen to manifest and life-threatening forms. In contrast to the wide list of diseases caused by streptococci registered in ICD-10, in our country a direct indication of streptococcal etiology is usually applied only to scarlet fever, tonsillitis, streptoderma, rheumatic fever, rheumatic heart disease (valvular disease). In all other cases, in the absence of verification of the pathogen, they try not to include the streptococcal nature of the disease in the diagnosis. This applies to pharyngitis, pneumonia, infectious dermatitis, etc. Recently, in addition to the bacteriological method, a rapid test for group A beta-hemolytic streptococcus (GABHS) is often used to confirm streptococcal etiology. The diagnostic capabilities of this technique are low, and therefore a comprehensive clinical and laboratory examination is recommended to diagnose streptococcal infection. Carriers of streptococcus do not require antibacterial therapy. Another thing is for patients with tonsillitis, scarlet fever, suspicion of the development of rheumatic fever, acute post-streptococcal glomerulonephritis. The author discusses and critically comprehends the complex problems of streptococcal infection in children and adolescents from the perspective of outpatient nursing practice.

Full Text

Restricted Access

About the authors

Konstantin I. Grigoryev

FSАEI HE N.I. Pirogov RNRMU MOH Russia

Author for correspondence.
Email: k-i-grigoryev@yandex.ru
ORCID iD: 0000-0002-4546-1092

Doctor of Medical Sciences, Professor of the Department of Pediatrics with Infectious Diseases in Children, Faculty of Additional Professional Education, Institute of Continuing Education and Professional Development, Editor-in-Chief of the journal “Meditsinskaya sestra (The Nurse)”

Russian Federation, Moscow

References

  1. Захарова И.Н., Бережная И.В., Дмитриева Д.К. и др. Ось «микробиота – кишечник – глаз». Педиатрия. Consilium Medicum. 2024; (2): 179–186. [Zakharova IN, Berezhnaya IV, Dmitrieva DK, Pupykina VV. Axis «microbiota – gut – eye»: A review. Pediatriуа. Consilium Medicum. 2024; (2): 179–186. (In Russ.)] doi: 10.26442/26586630.2024.2.202976
  2. Lancefield R.C., Freimer E.H. Type-specific polysaccharide antigens of group B streptococci. J Hyg (Lond). 1966; (64): 191–203. doi: 10.1017/S0022172400040456
  3. Аксенова А.В., Абельдяев Д.В., Глушкова Е.В. Эпидемиологические аспекты стрептококковых и постстрептококковых заболеваний в Российской Федерации на современном этапе. Клиницист. 2020; 14 (1–2): 14–23. [Aksenova A.V., Abeldyaev D.V., Glushkova E.V. Epidemiological aspects of streptococcal and post-streptococcal diseases in the Russian Federation at the present stage. Klinitsist. 2020; 14 (1–2): 14–23 (In Russ.)] doi: 10.17650/1818-8338-2020-14-1-2-14-23
  4. Parnaby M.G., Carapetis J.R. Rheumatic fever in indigenous Australian children. J Pediatr Child Health 2010; 46 (9): 527–533. doi: 10.1111/j.1440-1754.2010.01841.x
  5. Покровский В.И., Брико Н.И., Ряпис Л.А. Стрептококки и стрептококкозы. М.: ГЭОТАР-Медиа, 2006. 544 с. [Pokrovsky V.I., Briko N.I., Ryapis L.A. Streptococci and streptococcosis. M.: GEOTAR-Media, 2006. 544 p. (In Russ.)]
  6. Яковлев А.А. О возможных механизмах развития эпидемического процесса. Эпидемиология и инфекционные болезни. Актуальные вопросы. 2014; (6): 52–56. [Yakovlev A.A. On possible mechanisms for the development of an epidemic process. Epidemiologiya i infektsionnyye bolezni. Aktual’nyye voprosy. 2014; (6): 52–56. (In Russ.)]
  7. Mejia ME, Robertson CM, Patras KA. Interspecies Interactions within the Host: the Social Network of Group B Streptococcus. Infect Immun. 2023 Apr 18; 91 (4): e0044022. doi: 10.1128/iai.00440-22
  8. Jump R.L.P., Wilson B.M., Baechle D. et al. Risk factors and mortality rates associated with invasive group B Streptococcus infections among patients in the US Veterans Health Administration. JAMA Netw Open 2019; 2:e1918324. doi: 10.1001/jamanetworkopen.2019.18324
  9. Ling J, Hryckowian AJ. Re-framing the importance of Group B Streptococcus as a gut-resident pathobiont. Infect Immun. 2024 Sep 10; 92 (9): e0047823. doi: 10.1128/iai.00478-23
  10. Карпеева Ю.С., Новикова В.П., Хавкин А.И. и др. Микробиота и болезни человека: возможности диетической коррекции. Рос. вестн. перинатол. и педиатр. 2020; 65 (5): 116–125. [Karpeeva Yu.S., Novikova V.P., Khavkin A.I. et al. Microbiota and human diseases: possibilities of dietary correction. Ros vestn perinatol i pediatr 2020; 65 (5): 116–125. (In Russ.)] doi: 10.21508/1027–4065–2020–65–5–116–125
  11. Баландина В.Ю., Пурсанова А.Е., Свириденко А.В. Роль стрептококков в патогенезе заболеваний зубочелюстной системы [Электронный ресурс: Огарев-online. 2022; (12). Режим доступа: https://journal.mrsu.ru/arts/rol-streptokokkov-v-patogeneze-zabolevanij-zubochelyustnoj-sistem]. [Balandina V.Yu., Pursanova A.E., Sviridenko A.V. The role of streptococci in the pathogenesis of diseases of the dental system [Electronic resource: Ogarev-online. 2022; (12). Access mode: https://journal.mrsu.ru/arts/rol-streptokokkov-v-patogeneze-zabolevanij-zubochelyustnoj-sistem] (In Russ.)]
  12. Комарова О.Н., Хавкин А.И. Взаимосвязь стресса, иммунитета и кишечной микробиоты. Педиатрическая фармакология. 2020; 17 (1): 18–24. [Komarova O.N., Khavkin A.I. The relationship between stress, immunity and intestinal microbiota. Pediatricheskaya farmakologiya. 2020; 17 (1): 18–24. (In Russ.)] doi: 10.15690/pf.v17i1.2078
  13. Тамразова О.Б., Шмелева Е.А., Миронова А.К. и др. Современный взгляд на этиопатогенез, клинические проявления и лечение пиодермий у детей. Медицинский совет. 2020; (1): 118–129. [Tamrazova O.B., SHmeleva E.A., Mironova A.K. et al. Modern view on etiopathogenesis, clinical manifestations and treatment of pyodermas in children. Meditsinskiy sovet. 2020; (1): 118–129. (In Russ.)] doi: 10.21518/2079-701X-2020-1-118-129
  14. Cen H., Jin R., Yin J. et al. Risk Factors for Predicting Mortality and Amputation of Patients with Necrotizing Soft-Tissue Infections: Retrospective Analysis of 111 Cases from a Single Medical Center. Emerg Med Int. 2023 Nov 11; 2023: 6316896. doi: 10.1155/2023/6316896
  15. Брико Н.И., Никитин Н.В., Глушкова Е.В. и др. Клинические проявления скарлатины у детей в мегаполисе на современном этапе. Российский медицинский журнал. 2024; 30 (4): 336–347. DOI: https://doi.org/10.17816/medjrf630935
  16. Брико Н.И., Глушкова Е.В., Какорина Е.П. и др. Стрептококковая (группы А) инфекция в России: состояние проблемы и тенденции развития. Журнал инфектологии. 2019; 1 (1): 7–12. [Briko N.I., Nikitin N.V., Glushkova E.V. et al. Clinical manifestations of scarlet fever in children in the megalopolis at the present. RMJ. 2024; 30 (4): 336–347. (In Russ.)] doi: 10.22625/2072-6732-2019-11-1-7-16
  17. Rwebembera J., Marangou J., Mwita J.C. et al. 2023 World Heart Federation guidelines for the echocardiographic diagnosis of rheumatic heart disease. Nat Rev Cardiol. 2024 Apr; 21 (4): 250–263. doi: 10.1038/s41569-023-00940-9.
  18. Balasubramanian R., Marks S.D. Post-infectious glomerulonephritis. Paediatr Int Child Health. 2017; 37 (4): 240–247. doi: 10.1080/20469047.2017.1369642.
  19. Костик И. А., Костик М. М. Современные подходы к диагностике и лечению PANS/PANDAS. Вопросы современной педиатрии. 2019; 18 (5): 324–338. [Kostik I. A., Kostik M.M. Current Approaches to PANS/PANDAS Diagnostics and Management. Voprosy sovremennoi pediatrii. 2019; 18 (5): 324–338. (In Russ.)] doi: 10.15690/vsp.v18i5.2055
  20. Chang K., Frankovich J., Cooperstock M. et al. Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS Consensus Conference. J Child Adolesc Psychopharmacol. 2015; 25 (1): 3–13. doi: 10.1089/cap.2014.0084
  21. Bottoms N., Rice S., Veerapandiyan A. Editorial: Pediatric autoimmune neuropsychiatric syndrome. Front Behav Neurosci. 2024 Aug 6; 18: 1467469. doi: 10.3389/fnbeh.2024
  22. Белов Б.С. А-стрептококковая инфекция глотки: диагностика и рациональная антибактериальная терапия. Антибиотики и химиотерапия. 2018; 63 (5–6): 68–75. [Belov B.S. A-streptococcal infection of the pharynx: diagnosis and rational antibacterial therapy. Antibiotiki i khimioterapiya. 2018; 63 (5–6): 68–75. (In Russ.)]
  23. Мальцева Г.С., Гринчук О.Н. Место антибактериальной терапии при стрептококковой инфекции. Медицинский совет. 2019; (20): 91–96. [Maltseva G.S., Grinchuk O.N. Place of antibacterial therapy for streptococcal infection. Meditsinskiy sovet. 2019; (20): 91–96. (In Russ.)] doi: 10.21518/2079-701X-2019-20-91-96
  24. Новосад Е.В., Бевза С.Л., Обольская Н.М. и др. Носительство β-гемолитического стрептококка группы А у детей: проблема дифференциальной диагностики. Детские инфекции. 2018; 17 (2): 52–57. [Novosad E.V., Bevza S.L., Obolskaya N.M. et al. β-hemolytic streptococcus group A carrier in children: the problem of differential diagnosis. Detskie Infektsii. 2018; 17 (2):52–57. (In Russ.)] https://doi.org/10.22627/2072-8107-2018-17-2-52-57
  25. Санталова Г.В., Лебедев П.А., Гаранин А.А. и др. Кардиальные и некардиальные проявления инфекции, вызванной β-гемолитическим стрептококком группы А. РМЖ. Мать и дитя. 2022; 5 (1): 63–71. [Santalova G.V., Lebedev P.A., Garanin A.A. et al. Cardiac and non-cardiac manifestations of infection caused by group A β-hemolytic streptococcus. RMJ. Mat’ i ditya.2022; 5 (1): 63–71. (In Russ.)] doi: 10.32364/2618-8430-2022-5-1-63-71

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Russkiy Vrach Publishing House